Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...
The 29th edition of Expomed Eurasia took place on March 17-19, 2022 in Istanbul, Turkey. With 600+ exhibitors from Turkey and around world & 19000 visitors only from Turkey and 5000 intern...
A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...
On June 28, the “National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crab Marine Biomedicine Industrial Park” invested and c...
Era Biology will host global live webinar at 21th June 2022 16:00 (GMT +08:00). The webinar will focus on providing comprehensive solution for invasive fungal disease diagnosis by using Full-automa...